Talaris Therapeutics to Present at William Blair’s Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event

Rhea-AI Summary

Talaris Therapeutics (Nasdaq: TALS), a late-stage cell therapy company, announced that its CEO, Scott Requadt, will present at William Blair’s Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event on September 28, 2022, at 1:00 PM ET. The presentation will focus on transforming the standard of care in solid organ transplantation and severe immune and blood disorders. A live webcast will be available on Talaris' website and archived for 30 days.

Talaris operates from Boston, MA, with facilities in Louisville, KY, and research in Houston, TX.

BOSTON and LOUISVILLE, Ky., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive Officer of Talaris, will present at William Blair’s Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event on Wednesday, September 28, 2022 at 1:00 PM ET.

A live webcast of the presentation will be available on the investors section of the Talaris website at www.talaristx.com. After the live webcast, the event will remain archived on the Talaris website for 30 days.

About Talaris Therapeutics
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing facility in Louisville, KY, and additional research operations in Houston, TX.

Media Contact
Lisa Raffensperger
Ten Bridge Communications
lisa@tenbridgecommunications.com
(617) 903-8783

Investor Contact
Chris Brinzey
ICR Westwicke
chris.brinzey@westwicke.com
(339) 970-2843

FAQ

What is the date and time of Talaris Therapeutics' presentation at the William Blair event?

Talaris Therapeutics' presentation is scheduled for September 28, 2022, at 1:00 PM ET.

Who is presenting for Talaris Therapeutics at the virtual event?

Scott Requadt, the Chief Executive Officer of Talaris Therapeutics, will present.

Where can I watch the Talaris Therapeutics presentation?

The presentation will be available via a live webcast on the investors section of the Talaris website.

How long will the Talaris Therapeutics presentation be available online?

The presentation will remain archived on the Talaris website for 30 days after the event.

What is Talaris Therapeutics known for?

Talaris Therapeutics is known for developing therapies that aim to transform the standard of care in solid organ transplantation and severe immune and blood disorders.